Gradient Investments’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-128
Closed -$17.4K 1331
2024
Q2
$17.4K Hold
128
﹤0.01% 660
2024
Q1
$16.5K Sell
128
-448
-78% -$54.1K ﹤0.01% 581
2023
Q4
$65.9K Buy
576
+128
+29% +$12.8K ﹤0.01% 490
2023
Q3
$40.8K Hold
448
﹤0.01% 544
2023
Q2
$50.5K Buy
448
+8
+2% +$846 ﹤0.01% 501
2023
Q1
$46.1K Hold
440
﹤0.01% 508
2022
Q4
$48.7K Hold
440
﹤0.01% 513
2022
Q3
$38K Buy
+440
New +$40K ﹤0.01% 524
2019
Q1
Sell
-164
Closed -$11K 1021
2018
Q4
$11K Buy
+164
New +$11.3K ﹤0.01% 569

Other funds holding XYL

Gradient Investments's XYL Position: Q3 2024 in Review

Gradient Investments sold out of Xylem (XYL) in Q3 2024, closing a stake of 128 shares — an estimated $17.4K sold.

Gradient Investments first reported a position in XYL in Q4 2018 and held it in 9 quarters. The position peaked at $65.9K in Q4 2023. 1,016 funds tracked by Wall St. Rank hold XYL as of Q3 2024.

  • Gradient Investments reported no remaining Xylem position as of Q3 2024 after selling out during the quarter.
  • Gradient Investments sold 128 Xylem shares in Q3 2024, an estimated $17.4K.
  • Gradient Investments first reported a position in Xylem in Q4 2018 and held it in 9 quarters.
  • Gradient Investments's Xylem position peaked at $65.9K in Q4 2023.
  • 1,016 funds tracked by Wall St. Rank held Xylem as of Q3 2024.

Based on Gradient Investments's 13F filing for Q3 2024, filed 15 Oct 2024.